FDA Inspection 1038511 — Aarti Drugs Limited
The FDA completed an inspection of Aarti Drugs Limited on December 8, 2017 in Palghar. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI) (OAI)
- End Date
- December 8, 2017
- Fiscal Year
- 2018
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Palghar (India)